Just about everyone should get a flu shot in September or October. It’s especially important for people living with cancer, cancer survivors, and their caregivers.
What to Know About Cancer Care and Research for People 65+: A Q&A With Patient Advocate Beverly Canin
In this podcast, Dr. Allison Magnuson talks with patient advocate Beverly Canin about cancer care for people age 65 or older, including what they can expect, how to advocate for themselves, and what they should know about participating in cancer research.
2022 ASCO Annual Meeting Research Round Up: Advances in Treating Multiple Myeloma, Breast Cancer, and Cancer in People 60 and Older
In this podcast, members of the American Society of Clinical Oncology (ASCO) discuss new research presented at the 2022 ASCO Annual Meeting in multiple myeloma, breast cancer, and cancer in people age 60 or older.
2022 ASCO Annual Meeting: Improving Standard Care for Advanced Pancreatic Cancer and Older Adults with Mantle Cell Lymphoma
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma.
2021 ASCO Annual Meeting Research Round Up: New Research in Gynecologic Cancers, Advanced Melanoma, and Cancer in People 65 or Older
In this webinar, experts discuss new research in gynecologic cancers, advanced melanoma, and cancer in people age 65 or older presented at the 2021 ASCO Annual Meeting.
Dr. William Dale discusses 5 key studies presented at the SIOG 2020 Annual Meeting Online that involve improvements in evaluating, caring for, and treating people with cancer who are 60 or older.
In this podcast, 3 experts discuss what it means to have the capacity to make decisions during cancer, and what families and caregivers should know if they need to make decisions on behalf of someone else.
In this podcast, Cancer.Net Associate Editors discuss new research from the ASCO20 Virtual Scientific Program and what it means for patients.
In this Q&A, Dr. Enrique Soto discusses the benefits and potential challenges adults age 65 or older may experience when finding or participating in a cancer clinical trial.
ASCO20 Virtual Scientific Program: Effect of Quitting Smoking on Lung Cancer Survival, Maintenance Therapy for Recurrent Ovarian Cancer, Geriatric Assessments, Medicaid Expansion and Overall Cancer Mortality, and Videoconferencing for Caregivers
Read early research highlights just released from the ASCO20 Virtual Scientific Program. They include studies on quitting smoking and lung cancer survival, recurrent ovarian cancer treatment, geriatric assessment for patients receiving systemic therapy, how Medicaid expansion is impacting U.S. cancer mortality, and using videoconferencing with long-distance caregivers.